Arendash, Gary <br/><br/>
A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.  [electronic resource] 

 -  Journal of Alzheimer's disease : JAD  2019 
 - 57-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-8908 
<br/><br/><label>Standard No.: </label>10.3233/JAD-190367  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--diagnostic imaging<br/>Amyloid beta-Peptides--blood<br/>Cognition<br/>Female<br/>Humans<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Neuroimaging<br/>Neuropsychological Tests<br/>Transcranial Magnetic Stimulation--adverse effects<br/>Treatment Outcome<br/>tau Proteins--blood